2.39
price down icon2.45%   -0.06
pre-market  Vorhandelsmarkt:  2.35   -0.04   -1.67%
loading
Schlusskurs vom Vortag:
$2.45
Offen:
$2.49
24-Stunden-Volumen:
2.42M
Relative Volume:
0.66
Marktkapitalisierung:
$543.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-179.82M
KGV:
-1.797
EPS:
-1.33
Netto-Cashflow:
$-159.16M
1W Leistung:
+0.00%
1M Leistung:
-7.00%
6M Leistung:
+102.54%
1J Leistung:
+173.55%
1-Tages-Spanne:
Value
$2.35
$2.49
1-Wochen-Bereich:
Value
$2.2808
$2.52
52-Wochen-Spanne:
Value
$0.6617
$3.60

Gossamer Bio Inc Stock (GOSS) Company Profile

Name
Firmenname
Gossamer Bio Inc
Name
Telefon
(858) 684-1300
Name
Adresse
3115 MERRYFIELD ROW, SAN DIEGO, CA
Name
Mitarbeiter
145
Name
Twitter
@GossamerBio
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
GOSS's Discussions on Twitter

Vergleichen Sie GOSS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GOSS
Gossamer Bio Inc
2.39 560.76M 0 -179.82M -159.16M -1.33
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-10 Hochstufung UBS Neutral → Buy
2025-07-14 Eingeleitet Scotiabank Sector Outperform
2024-06-25 Eingeleitet Oppenheimer Outperform
2024-04-05 Fortgesetzt Wedbush Outperform
2023-07-27 Herabstufung UBS Buy → Neutral
2023-03-07 Herabstufung Raymond James Outperform → Mkt Perform
2023-03-01 Eingeleitet Guggenheim Neutral
2022-12-07 Herabstufung Barclays Overweight → Equal Weight
2022-12-07 Herabstufung JP Morgan Neutral → Underweight
2022-12-07 Herabstufung SMBC Nikko Outperform → Neutral
2022-10-20 Eingeleitet Goldman Buy
2022-09-21 Eingeleitet JP Morgan Neutral
2022-09-19 Eingeleitet Wedbush Outperform
2022-04-18 Eingeleitet Raymond James Outperform
2022-04-06 Eingeleitet UBS Buy
2022-01-10 Hochstufung SMBC Nikko Neutral → Outperform
2021-11-09 Fortgesetzt Cantor Fitzgerald Overweight
2021-09-21 Fortgesetzt Piper Sandler Overweight
2020-06-29 Eingeleitet H.C. Wainwright Buy
2020-04-22 Eingeleitet Piper Sandler Overweight
2020-02-27 Eingeleitet Barclays Overweight
2019-12-03 Fortgesetzt BofA/Merrill Buy
2019-10-30 Eingeleitet Berenberg Buy
2019-03-05 Eingeleitet Barclays Overweight
2019-03-05 Eingeleitet BofA/Merrill Buy
2019-03-05 Eingeleitet Evercore ISI Outperform
2019-03-05 Eingeleitet SVB Leerink Outperform
Alle ansehen

Gossamer Bio Inc Aktie (GOSS) Neueste Nachrichten

pulisher
04:30 AM

Will Gossamer Bio Inc. stock recover faster than marketQuarterly Profit Report & Expert Approved Momentum Ideas - newser.com

04:30 AM
pulisher
02:30 AM

How to use Fibonacci retracement on Gossamer Bio Inc.2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com

02:30 AM
pulisher
Nov 03, 2025

Will Gossamer Bio Inc. (4GB) stock keep raising dividendsPortfolio Risk Summary & Stock Portfolio Risk Management - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Gossamer Bio Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView

Nov 03, 2025
pulisher
Nov 03, 2025

Why Gossamer Bio Inc. (4GB) stock could outperform next yearWeekly Profit Recap & Free Long-Term Investment Growth Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Gossamer Bio Inc. stock affected by interest rate hikes2025 Historical Comparison & Weekly Top Gainers Trade List - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why retail investors favor Gossamer Bio Inc. stock2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is now a turning point for Gossamer Bio Inc.July 2025 Big Picture & Trade Opportunity Analysis - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Strategies to average down on Gossamer Bio Inc.2025 Breakouts & Breakdowns & Risk Controlled Stock Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What Fibonacci levels say about Gossamer Bio Inc. reboundJuly 2025 Fed Impact & Expert Approved Momentum Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What valuation multiples suggest for Gossamer Bio Inc. stock2025 Volatility Report & AI Powered Buy/Sell Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What Wall Street predicts for Gossamer Bio Inc. stock price2025 Institutional Moves & Real-Time Volume Analysis - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Gossamer Bio Inc. (4GB) stock issue positive guidancePortfolio Return Report & Growth-Oriented Investment Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can momentum traders help lift Gossamer Bio Inc.2025 Market Outlook & Capital Efficient Trade Techniques - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Gossamer Bio Inc. (4GB) stock nearing a technical breakoutMarket Risk Report & Free High Accuracy Swing Entry Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Gossamer Bio Inc. (4GB) stock supported by strong fundamentals2025 Volatility Report & Stepwise Swing Trade Plans - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Why millennials buy Gossamer Bio Inc. (4GB) stockQuarterly Profit Review & Real-Time Buy Signal Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Ranking Gossamer Bio Inc. among high performing stocks via toolsEarnings Beat & High Accuracy Buy Signal Tips - newser.com

Nov 02, 2025
pulisher
Oct 31, 2025

Institutional Investors Control 62% of Gossamer Bio, Inc. (NASDAQ:GOSS) and Were Rewarded Last Week After Stock Increased 16% - 富途牛牛

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 05:26:53 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Gossamer Bio (GOSS) to Release Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Does Gossamer Bio Inc. show high probability of reboundOptions Play & Free Community Supported Trade Ideas - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Using portfolio simulators with Gossamer Bio Inc. includedWeekly Loss Report & Free Fast Gain Swing Trade Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Why Gossamer Bio Inc. stock remains undervaluedJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Gossamer Bio, Inc. (NASDAQ:GOSS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Oct 31, 2025

Finanzdaten der Gossamer Bio Inc-Aktie (GOSS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):